Patient Identification for Clinical Trials Through AI and Real-World Data, Upcoming Webinar Hosted by Xtalks
In this free webinar, gain insight into the benefits and challenges of utilizing electronic health record (EHR) data as a...
Pharmaceutical
PhaseV Partners with Bioforum to Bring AI-Powered Design Optimization to Clinical Trial Sponsors Worldwide
Integration of PhaseV's Trial Optimizer with Bioforum's Biometric CRO Services Creates an End-to-End Solution for Smarter, Faster, and More Efficient...
PhaseV Partners with Bioforum to Bring AI-Powered Design Optimization to Clinical Trial Sponsors Worldwide
Integration of PhaseV's Trial Optimizer with Bioforum's Biometric CRO Services Creates an End-to-End Solution for Smarter, Faster, and More Efficient...
Improving Clinical Response Signaling in Rare Disease Studies with Targeted Endpoint Data Quality Programs, Upcoming Webinar Hosted by Xtalks
In this free webinar, gain insight into strategies to improve data quality monitoring in rare disease clinical trials, including eCOA form optimization,...
Helix BioPharma Announces Presentation at Q3 Investor Summit Virtual on 16 September 2025
TORONTO, ON / ACCESS Newswire / September 9, 2025 / Helix BioPharma Corp. (TSX:HBP)(OTC:HBPCF)(FRANKFURT:HBP0) ("Helix" or the "Company"), a clinical-stage...
Ireland’s Digital Health Reality Check 2025: Trust, Cybersecurity, and Innovation Readiness
Black Book Mid Year Update on Irish Health IT Adoption and Vendor Performance DUBLIN, IE / ACCESS Newswire / September...
Working Together: DaVita Celebrates Joint Efforts To Advance Kidney Health Awareness and Access to Care
NORTHAMPTON, MA / ACCESS Newswire / September 9, 2025 / Kidney disease affects an estimated 35 million Americans, with 90%...
GEOH Secures Over $30M Growth Investment from Council Capital and Affiliates
Investment will accelerate GEOH's expansion as a leading end-to-end software and services platform for home care agencies. INDIANAPOLIS, IN /...
West African Leaders Commit to Advance Lassa Fever Vaccine for the Region
In an historic moment for regional solidarity and leadership, West African Ministers of Health pledge their joint commitment to advance...
FDA Highlights Benzene Presence in Benzoyl Peroxide Acne Products – CLn Acne Cleanser Offers an Alternative
Following new safety concerns from the U.S. Food and Drug Administration (FDA) regarding benzoyl peroxide (BPO) acne products, CLn Skin...
Medical Care Technologies Inc. (OTC PINK:MDCE) Projects Debt-Free Status by Year-End Driven by Strong Subsidiary Growth
"Company anticipates achieving debt-free status by year-end, reinforcing commitment to AI-driven healthcare technologies" MESA, ARIZONA / ACCESS Newswire / September...
Ankle & Foot Centers of America Opens New East Cobb Location
The new location expands access to advanced podiatric care in one of metro Atlanta's most active and growing communities. ATLANTA,...
SpendMend Unveils Trulla Analytics 2.0: Analytics That Take Action(TM)
First Wave of 10-Report Rollout Empowers IDNs with Faster Insights into Pharmacy Spend, Pricing, and Compliance GRAND RAPIDS, MI /...
Phase 1 Equity Announces It’s Seventh Practice Addition Of The Year, Bringing On A Multi-Doctor Orthodontic Practice Located in New Jersey
CHICAGO, IL / ACCESS Newswire / September 9, 2025 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for...
Michael Castanon Nominated for Executive of the Year 2025 in Southern California
Michael Castanon, Founder and CEO of Alter Behavioral Health, Has Been Nominated for Executive of the Year 2025 IRVINE, CALIFORNIA...
1933 Industries Closes Repurchase and Cancellation of Convertible Debentures
VANCOUVER, BC / ACCESS Newswire / September 9, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF), a...
NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025
SHELTON, CONNECTICUT / ACCESS Newswire / September 9, 2025 / NanoViricides, Inc. (NYSE American:NNVC ) (the "Company"), a clinical stage...
PillSafe Launches SAFE Investment Opportunity to Advance the First Wireless Smart Prescription Bottle Technology System
Launch timetable is now imminent for developers of a revolutionary system for medication management as they open an initial SAFE...
Telomir Pharmaceuticals Announces New Cancer Data in Aggressive Human Prostate Cancer Cells Showing Telomir-1 Resets DNA Methylation to Reactivate CDKN2A, a Master Tumor Suppressor, Outperforming Rapamycin and Chemotherapy
New preclinical findings highlight Telomir-1's ability to reverse CDKN2A gene silencing by DNA methylation, reactivating this gene - often called...
Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study
- Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients -- Gemini could...